Persistence to COPD therapies and impact on exacerbations: a French claims data study

F. Dalon (Lyon, France), G. Devouassoux (Lyon, France), M. Belhassen (Lyon, France), G. Nachbaur (Rueil-Malmaison, France), C. Correia Da Silva (Rueil-Malmaison, France), L. Sail (Rueil-Malmaison, France), C. Chouaid (Créteil, France), E. Van Ganse (Lyon, France)

Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Dalon (Lyon, France), G. Devouassoux (Lyon, France), M. Belhassen (Lyon, France), G. Nachbaur (Rueil-Malmaison, France), C. Correia Da Silva (Rueil-Malmaison, France), L. Sail (Rueil-Malmaison, France), C. Chouaid (Créteil, France), E. Van Ganse (Lyon, France). Persistence to COPD therapies and impact on exacerbations: a French claims data study. 2273

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


The long-term clinical and economic impact of COPD exacerbations: an observational study (SHERLOCK)
Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases
Year: 2020




Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study
Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019
Year: 2020



Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Acute exacerbation of COPD patients therapy priorities: A survey study
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021


Dispensed asthma therapy and medical resource utilisation in asthma patients: results from the L777 observational study
Source: Annual Congress 2009 - Epidemiology of asthma
Year: 2009


Systematic review: Does antibiotic treatment duration affect the outcomes of asthma and COPD exacerbations?
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017



Challenges in classification of asthma severity from prescription data: a pilot study
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009


A comparison of the management of COPD exacerbations in six European hospitals: demographics and baseline data
Source: Annual Congress 2008 - Management of COPD
Year: 2008



The Spanish national clinical audit on COPD exacerbations. results of a pilot study: spirometry outcomes
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Does long-term macrolide treatment reduce asthma exacerbations? An individual patient data meta-analysis
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
Source: ERJ Open Res, 7 (3) 00242-2021; 10.1183/23120541.00242-2021
Year: 2021



The Spanish national clinical audit on COPD exacerbations. Results of a pilot study: main outcomes
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008


Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

COPD exacerbations: impact and prevention
Source: Breathe 2013; 9: 434-440
Year: 2013

A global survey conducted to determine frequency of exacerbations in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013


The ICE study, Italian costs for exacerbations in COPD: a project of the Italian Association for COPD
Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD
Year: 2003


Real-life COPD patients compared to large trial populations: An UNLOCK external validity study
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013

Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016